|
cancer prevention |
COLLOQUIUM |
Immune-Based Approaches to the Prevention and Therapy of Gastrointestinal MalignanciesKenneth W. Hance, Ph.D., M.P.H.Speaker Dr. Hance is a Research Fellow in the Laboratory of Tumor Immunology and Biology at the National Cancer Institute, NIH, Bethesda, MD. Learning Objective Basic understanding of innate and adaptive immune function, overview of vaccine development and translational research in the field of tumor immunology, and discuss the opportunities and limitations in using cancer vaccines for the prevention and management of cancer. Target Audience Researchers and clinicians actively involved in topics that relate to cancer prevention and control Date/Time/Place Friday, October 26, 11:00 a.m. For Additional Information Office of Preventive Oncology If you are a person with a disability and require any assistive device, services or other reasonable accommodation to participate in this activity, please contact the Office of Preventive Oncology at 301-496-8640 at least one week in advance of the lecture date to discuss your accommodation needs. |
Educational objectives: To better comprehend current research in various aspects of cancer prevention and control, including current challenges and methods used by investigators to address gaps, advance the field, and promote application of successful strategies, and to better identify various bio-statistical methods and appropriate conditions for application in cancer prevention and control research.
The National Institutes of Health/Foundation for Advanced Education in the Sciences (NIH/FAES) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The NIH/FAES designates this educational activity for a maximum of 37 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Department of Health and Human Services, National Institutes of Health